XeriSol glucagon
17225
Phase 1 small_molecule completed
Quick answer
XeriSol glucagon for Type1diabetes is a Phase 1 program (small_molecule) at Xeris Biopharma Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Xeris Biopharma Holdings
- Indication
- Type1diabetes
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed